nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—appendage—atherosclerosis	0.0373	0.118	CbGeAlD
Amlexanox—IL3—connective tissue—atherosclerosis	0.0365	0.115	CbGeAlD
Amlexanox—FGF1—artery—atherosclerosis	0.0267	0.0841	CbGeAlD
Amlexanox—FGF1—endothelium—atherosclerosis	0.0225	0.071	CbGeAlD
Amlexanox—FGF1—blood vessel—atherosclerosis	0.0208	0.0655	CbGeAlD
Amlexanox—S100A13—connective tissue—atherosclerosis	0.0173	0.0545	CbGeAlD
Amlexanox—S100A12—connective tissue—atherosclerosis	0.0171	0.0538	CbGeAlD
Amlexanox—S100A13—cardiovascular system—atherosclerosis	0.0151	0.0475	CbGeAlD
Amlexanox—S100A12—cardiovascular system—atherosclerosis	0.0149	0.0468	CbGeAlD
Amlexanox—S100A13—adipose tissue—atherosclerosis	0.0133	0.0419	CbGeAlD
Amlexanox—S100A12—adipose tissue—atherosclerosis	0.0131	0.0413	CbGeAlD
Amlexanox—FGF1—connective tissue—atherosclerosis	0.0107	0.0336	CbGeAlD
Amlexanox—S100A13—liver—atherosclerosis	0.00931	0.0294	CbGeAlD
Amlexanox—FGF1—cardiovascular system—atherosclerosis	0.00927	0.0292	CbGeAlD
Amlexanox—S100A12—liver—atherosclerosis	0.00919	0.029	CbGeAlD
Amlexanox—PDE4D—adipose tissue—atherosclerosis	0.00874	0.0275	CbGeAlD
Amlexanox—FGF1—adipose tissue—atherosclerosis	0.00818	0.0258	CbGeAlD
Amlexanox—PDE4A—adipose tissue—atherosclerosis	0.00773	0.0244	CbGeAlD
Amlexanox—PDE4D—liver—atherosclerosis	0.00613	0.0193	CbGeAlD
Amlexanox—FGF1—liver—atherosclerosis	0.00573	0.0181	CbGeAlD
Amlexanox—PDE4B—adipose tissue—atherosclerosis	0.00461	0.0145	CbGeAlD
Amlexanox—PDE4B—liver—atherosclerosis	0.00323	0.0102	CbGeAlD
Amlexanox—Liver function test abnormal—Ezetimibe—atherosclerosis	0.0018	0.0655	CcSEcCtD
Amlexanox—Liver function test abnormal—Niacin—atherosclerosis	0.00157	0.0574	CcSEcCtD
Amlexanox—Liver function test abnormal—Pravastatin—atherosclerosis	0.00155	0.0565	CcSEcCtD
Amlexanox—Stomatitis—Niacin—atherosclerosis	0.00128	0.0467	CcSEcCtD
Amlexanox—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00113	0.0411	CcSEcCtD
Amlexanox—Paraesthesia—Rosuvastatin—atherosclerosis	0.00103	0.0377	CcSEcCtD
Amlexanox—Pain—Rosuvastatin—atherosclerosis	0.000984	0.0359	CcSEcCtD
Amlexanox—Nervous system disorder—Ezetimibe—atherosclerosis	0.000938	0.0342	CcSEcCtD
Amlexanox—Paraesthesia—Lovastatin—atherosclerosis	0.000876	0.0319	CcSEcCtD
Amlexanox—Paraesthesia—Ezetimibe—atherosclerosis	0.000859	0.0313	CcSEcCtD
Amlexanox—Pain—Lovastatin—atherosclerosis	0.000834	0.0304	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000826	0.0301	CcSEcCtD
Amlexanox—Paraesthesia—Simvastatin—atherosclerosis	0.000819	0.0299	CcSEcCtD
Amlexanox—Pain—Ezetimibe—atherosclerosis	0.000818	0.0298	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000788	0.0287	CcSEcCtD
Amlexanox—Pain—Simvastatin—atherosclerosis	0.00078	0.0284	CcSEcCtD
Amlexanox—Paraesthesia—Niacin—atherosclerosis	0.000752	0.0274	CcSEcCtD
Amlexanox—Paraesthesia—Pravastatin—atherosclerosis	0.000741	0.027	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Niacin—atherosclerosis	0.000723	0.0264	CcSEcCtD
Amlexanox—Headache—Rosuvastatin—atherosclerosis	0.000721	0.0263	CcSEcCtD
Amlexanox—Pain—Niacin—atherosclerosis	0.000717	0.0261	CcSEcCtD
Amlexanox—Pain—Pravastatin—atherosclerosis	0.000705	0.0257	CcSEcCtD
Amlexanox—Nausea—Rosuvastatin—atherosclerosis	0.000684	0.0249	CcSEcCtD
Amlexanox—Headache—Lovastatin—atherosclerosis	0.000611	0.0223	CcSEcCtD
Amlexanox—Headache—Ezetimibe—atherosclerosis	0.000599	0.0218	CcSEcCtD
Amlexanox—Nausea—Lovastatin—atherosclerosis	0.000579	0.0211	CcSEcCtD
Amlexanox—Headache—Simvastatin—atherosclerosis	0.000572	0.0208	CcSEcCtD
Amlexanox—Nausea—Ezetimibe—atherosclerosis	0.000568	0.0207	CcSEcCtD
Amlexanox—Nausea—Simvastatin—atherosclerosis	0.000542	0.0198	CcSEcCtD
Amlexanox—Headache—Niacin—atherosclerosis	0.000525	0.0191	CcSEcCtD
Amlexanox—Headache—Pravastatin—atherosclerosis	0.000517	0.0188	CcSEcCtD
Amlexanox—Nausea—Niacin—atherosclerosis	0.000498	0.0181	CcSEcCtD
Amlexanox—Nausea—Pravastatin—atherosclerosis	0.00049	0.0179	CcSEcCtD
Amlexanox—FGF1—Disease—PRKCG—atherosclerosis	0.000138	0.000211	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—atherosclerosis	0.000138	0.00021	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000137	0.000209	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PLG—atherosclerosis	0.000137	0.000209	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—atherosclerosis	0.000136	0.000208	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SOCS3—atherosclerosis	0.000136	0.000208	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PRKCG—atherosclerosis	0.000135	0.000207	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PDGFB—atherosclerosis	0.000135	0.000206	CbGpPWpGaD
Amlexanox—S100A12—Immune System—NFKB1—atherosclerosis	0.000134	0.000205	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—atherosclerosis	0.000134	0.000204	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—atherosclerosis	0.000134	0.000204	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK8—atherosclerosis	0.000132	0.000201	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPP1—atherosclerosis	0.000132	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—atherosclerosis	0.000132	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—NFKB1—atherosclerosis	0.000132	0.000201	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP3—atherosclerosis	0.000131	0.0002	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL8—atherosclerosis	0.000131	0.0002	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF2—atherosclerosis	0.000131	0.0002	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KNG1—atherosclerosis	0.000131	0.000199	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGTR1—atherosclerosis	0.00013	0.000198	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK8—atherosclerosis	0.00013	0.000198	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SOCS3—atherosclerosis	0.000129	0.000198	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—atherosclerosis	0.000128	0.000195	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—atherosclerosis	0.000127	0.000194	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOB—atherosclerosis	0.000127	0.000194	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—NFKB1—atherosclerosis	0.000127	0.000193	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PLG—atherosclerosis	0.000126	0.000193	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—atherosclerosis	0.000126	0.000193	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL8—atherosclerosis	0.000126	0.000192	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP3—atherosclerosis	0.000125	0.000191	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EDN1—atherosclerosis	0.000125	0.000191	CbGpPWpGaD
Amlexanox—FGF1—Disease—PDGFB—atherosclerosis	0.000125	0.00019	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF2—atherosclerosis	0.000124	0.00019	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL5—atherosclerosis	0.000124	0.000189	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PDGFB—atherosclerosis	0.000122	0.000186	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KNG1—atherosclerosis	0.000122	0.000186	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LPL—atherosclerosis	0.000121	0.000185	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ICAM1—atherosclerosis	0.000121	0.000185	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL8—atherosclerosis	0.000121	0.000185	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGTR1—atherosclerosis	0.000121	0.000185	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOB—atherosclerosis	0.000121	0.000184	CbGpPWpGaD
Amlexanox—S100A12—Immune System—STAT3—atherosclerosis	0.000121	0.000184	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL8—atherosclerosis	0.00012	0.000183	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SOCS3—atherosclerosis	0.00012	0.000183	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—atherosclerosis	0.000119	0.000182	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AGT—atherosclerosis	0.000119	0.000182	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EDN1—atherosclerosis	0.000119	0.000181	CbGpPWpGaD
Amlexanox—FGF1—Disease—CAV1—atherosclerosis	0.000118	0.00018	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL5—atherosclerosis	0.000118	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PLG—atherosclerosis	0.000118	0.00018	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRKCG—atherosclerosis	0.000118	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOA1—atherosclerosis	0.000118	0.00018	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—atherosclerosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—atherosclerosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—atherosclerosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP3—atherosclerosis	0.000116	0.000177	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CAV1—atherosclerosis	0.000116	0.000176	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOA1—atherosclerosis	0.000115	0.000176	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LPL—atherosclerosis	0.000115	0.000176	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK3—atherosclerosis	0.000115	0.000176	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF2—atherosclerosis	0.000115	0.000176	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—atherosclerosis	0.000115	0.000176	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPP1—atherosclerosis	0.000115	0.000175	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL8—atherosclerosis	0.000114	0.000174	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK3—atherosclerosis	0.000113	0.000173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRKCG—atherosclerosis	0.000112	0.000171	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOB—atherosclerosis	0.000112	0.000171	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SOCS3—atherosclerosis	0.000112	0.00017	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ESR1—atherosclerosis	0.000111	0.00017	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS2—atherosclerosis	0.000111	0.000169	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000111	0.000169	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—F2—atherosclerosis	0.00011	0.000168	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EDN1—atherosclerosis	0.00011	0.000168	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—atherosclerosis	0.00011	0.000167	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPP1—atherosclerosis	0.000109	0.000167	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL5—atherosclerosis	0.000109	0.000167	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—atherosclerosis	0.000109	0.000166	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NFKB1—atherosclerosis	0.000108	0.000165	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP3—atherosclerosis	0.000108	0.000165	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF2—atherosclerosis	0.000107	0.000164	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LPL—atherosclerosis	0.000107	0.000163	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK8—atherosclerosis	0.000107	0.000163	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PDGFB—atherosclerosis	0.000106	0.000162	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—atherosclerosis	0.000106	0.000162	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CG—atherosclerosis	0.000105	0.000161	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—atherosclerosis	0.000105	0.000161	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOB—atherosclerosis	0.000104	0.000159	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRKCG—atherosclerosis	0.000104	0.000158	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGT—atherosclerosis	0.000104	0.000158	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EDN1—atherosclerosis	0.000103	0.000157	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—atherosclerosis	0.000102	0.000155	CbGpPWpGaD
Amlexanox—FGF1—Disease—INS—atherosclerosis	0.000102	0.000155	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—atherosclerosis	0.000102	0.000155	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—atherosclerosis	0.000102	0.000155	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PDGFB—atherosclerosis	0.000101	0.000154	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPP1—atherosclerosis	0.000101	0.000154	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK3—atherosclerosis	0.000101	0.000154	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CAV1—atherosclerosis	0.000101	0.000154	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—atherosclerosis	0.000101	0.000154	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOA1—atherosclerosis	0.0001	0.000153	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—INS—atherosclerosis	9.97e-05	0.000152	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LPL—atherosclerosis	9.96e-05	0.000152	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGT—atherosclerosis	9.87e-05	0.000151	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—atherosclerosis	9.83e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—atherosclerosis	9.81e-05	0.00015	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—atherosclerosis	9.74e-05	0.000149	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—atherosclerosis	9.7e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ESR1—atherosclerosis	9.7e-05	0.000148	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRKCG—atherosclerosis	9.68e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—atherosclerosis	9.67e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—atherosclerosis	9.67e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—atherosclerosis	9.65e-05	0.000147	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CAV1—atherosclerosis	9.58e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—F2—atherosclerosis	9.58e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOA1—atherosclerosis	9.56e-05	0.000146	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPP1—atherosclerosis	9.43e-05	0.000144	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PDGFB—atherosclerosis	9.36e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Disease—SERPINE1—atherosclerosis	9.35e-05	0.000143	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK3—atherosclerosis	9.3e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ESR1—atherosclerosis	9.23e-05	0.000141	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—atherosclerosis	9.22e-05	0.000141	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CG—atherosclerosis	9.17e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SERPINE1—atherosclerosis	9.16e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGT—atherosclerosis	9.13e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—F2—atherosclerosis	9.12e-05	0.000139	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—atherosclerosis	9.03e-05	0.000138	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—atherosclerosis	8.95e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—atherosclerosis	8.95e-05	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—atherosclerosis	8.93e-05	0.000136	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CAV1—atherosclerosis	8.87e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOA1—atherosclerosis	8.85e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK3—atherosclerosis	8.78e-05	0.000134	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—atherosclerosis	8.74e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CG—atherosclerosis	8.73e-05	0.000133	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PDGFB—atherosclerosis	8.72e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—INS—atherosclerosis	8.68e-05	0.000132	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ESR1—atherosclerosis	8.54e-05	0.00013	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—atherosclerosis	8.54e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGT—atherosclerosis	8.52e-05	0.00013	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—F2—atherosclerosis	8.44e-05	0.000129	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—atherosclerosis	8.43e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—atherosclerosis	8.4e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK3—atherosclerosis	8.36e-05	0.000128	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—atherosclerosis	8.34e-05	0.000127	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—atherosclerosis	8.34e-05	0.000127	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—atherosclerosis	8.27e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CAV1—atherosclerosis	8.27e-05	0.000126	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—INS—atherosclerosis	8.26e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOA1—atherosclerosis	8.25e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—atherosclerosis	8.23e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—atherosclerosis	8.17e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—atherosclerosis	8.13e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CG—atherosclerosis	8.08e-05	0.000123	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—atherosclerosis	7.99e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SERPINE1—atherosclerosis	7.97e-05	0.000122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ESR1—atherosclerosis	7.97e-05	0.000122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—F2—atherosclerosis	7.87e-05	0.00012	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—atherosclerosis	7.78e-05	0.000119	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—atherosclerosis	7.76e-05	0.000118	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK3—atherosclerosis	7.74e-05	0.000118	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NFKB1—atherosclerosis	7.68e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—INS—atherosclerosis	7.65e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—atherosclerosis	7.63e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—atherosclerosis	7.61e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SERPINE1—atherosclerosis	7.59e-05	0.000116	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK8—atherosclerosis	7.54e-05	0.000115	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CG—atherosclerosis	7.53e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—atherosclerosis	7.52e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—atherosclerosis	7.49e-05	0.000114	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—atherosclerosis	7.4e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—atherosclerosis	7.38e-05	0.000113	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—atherosclerosis	7.33e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—atherosclerosis	7.25e-05	0.000111	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—INS—atherosclerosis	7.13e-05	0.000109	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SERPINE1—atherosclerosis	7.02e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—atherosclerosis	7.02e-05	0.000107	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—atherosclerosis	7.01e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NFKB1—atherosclerosis	6.94e-05	0.000106	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—atherosclerosis	6.9e-05	0.000105	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—atherosclerosis	6.9e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK8—atherosclerosis	6.82e-05	0.000104	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—atherosclerosis	6.8e-05	0.000104	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—atherosclerosis	6.8e-05	0.000104	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—atherosclerosis	6.75e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—atherosclerosis	6.7e-05	0.000102	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK3—atherosclerosis	6.59e-05	0.000101	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SERPINE1—atherosclerosis	6.55e-05	9.99e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—atherosclerosis	6.52e-05	9.96e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—atherosclerosis	6.43e-05	9.81e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—atherosclerosis	6.42e-05	9.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—atherosclerosis	6.37e-05	9.72e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—atherosclerosis	6.3e-05	9.61e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—atherosclerosis	6.27e-05	9.57e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—atherosclerosis	6.25e-05	9.54e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—atherosclerosis	6.24e-05	9.52e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—atherosclerosis	6.21e-05	9.48e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—atherosclerosis	6.11e-05	9.33e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—atherosclerosis	6.11e-05	9.32e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK3—atherosclerosis	6.08e-05	9.28e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NFKB1—atherosclerosis	6.04e-05	9.22e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK3—atherosclerosis	5.96e-05	9.1e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—atherosclerosis	5.95e-05	9.08e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK8—atherosclerosis	5.94e-05	9.07e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—atherosclerosis	5.92e-05	9.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—atherosclerosis	5.9e-05	9.01e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—atherosclerosis	5.81e-05	8.87e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—atherosclerosis	5.78e-05	8.82e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NFKB1—atherosclerosis	5.75e-05	8.78e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—atherosclerosis	5.75e-05	8.77e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—atherosclerosis	5.66e-05	8.63e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK8—atherosclerosis	5.65e-05	8.63e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—atherosclerosis	5.64e-05	8.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—atherosclerosis	5.55e-05	8.46e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—atherosclerosis	5.48e-05	8.37e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—atherosclerosis	5.43e-05	8.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—atherosclerosis	5.38e-05	8.21e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NFKB1—atherosclerosis	5.32e-05	8.12e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK8—atherosclerosis	5.23e-05	7.98e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—atherosclerosis	5.22e-05	7.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—atherosclerosis	5.22e-05	7.96e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK3—atherosclerosis	5.19e-05	7.92e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—atherosclerosis	5.17e-05	7.89e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—atherosclerosis	5.03e-05	7.68e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—atherosclerosis	5.02e-05	7.65e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NFKB1—atherosclerosis	4.96e-05	7.57e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK3—atherosclerosis	4.94e-05	7.54e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK8—atherosclerosis	4.88e-05	7.44e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—atherosclerosis	4.83e-05	7.37e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—atherosclerosis	4.82e-05	7.35e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—atherosclerosis	4.79e-05	7.31e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—atherosclerosis	4.78e-05	7.3e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK3—atherosclerosis	4.57e-05	6.97e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—atherosclerosis	4.5e-05	6.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—atherosclerosis	4.46e-05	6.81e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—atherosclerosis	4.45e-05	6.79e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—atherosclerosis	4.44e-05	6.78e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—atherosclerosis	4.43e-05	6.77e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—atherosclerosis	4.36e-05	6.65e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK3—atherosclerosis	4.26e-05	6.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—atherosclerosis	4.13e-05	6.31e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—atherosclerosis	4.1e-05	6.26e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—atherosclerosis	4.02e-05	6.13e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—atherosclerosis	3.79e-05	5.79e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—atherosclerosis	3.61e-05	5.51e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—atherosclerosis	3.5e-05	5.34e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—atherosclerosis	3.34e-05	5.1e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—atherosclerosis	3.33e-05	5.08e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—atherosclerosis	3.11e-05	4.75e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—atherosclerosis	3.08e-05	4.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—atherosclerosis	2.87e-05	4.39e-05	CbGpPWpGaD
